Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on June 8, 2026

Jun. 8, 2026

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Indeterminate GlobeNewswire

Jun. 8, 2026

Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets

Indeterminate GlobeNewswire

Jun. 8, 2026

Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors

Indeterminate GlobeNewswire

Jun. 8, 2026

Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY

Indeterminate GlobeNewswire

Jun. 8, 2026

Thriving in Place: HomeSight® Expands Offerings with New Engagement Experiences, Smart Home Insights, and Nationwide Professional Installation

Indeterminate GlobeNewswire

Jun. 8, 2026

Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program

Indeterminate GlobeNewswire

Jun. 8, 2026

Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

Indeterminate GlobeNewswire

Jun. 8, 2026

Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA

Indeterminate GlobeNewswire

Jun. 8, 2026

Standard BioTools and Treeline Biosciences Announce Merger Agreement

Indeterminate GlobeNewswire

Jun. 8, 2026

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Indeterminate GlobeNewswire

Jun. 8, 2026

[Latest] Surgical Masks Market Size Will Attain USD 6.76 Billion by 2034 Registering a Promising CAGR of 5.5% - Exclusive Report by ZMR | Global Surgical Masks Market Size, Share, Trends Analysis Report

Indeterminate GlobeNewswire

Jun. 8, 2026

MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire

Jun. 8, 2026

Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

Jun. 8, 2026

Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

Indeterminate GlobeNewswire

Jun. 8, 2026

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Indeterminate GlobeNewswire

Jun. 8, 2026

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Indeterminate GlobeNewswire

Jun. 8, 2026

Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

Indeterminate GlobeNewswire

Jun. 8, 2026

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Indeterminate GlobeNewswire

Jun. 8, 2026

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Indeterminate GlobeNewswire

Jun. 8, 2026

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Indeterminate GlobeNewswire